We recognise the importance of high quality research to promote the best evidence based care for our babies. As such, we are a research active unit and participate in many international, multi-centre research trials. We are currently recruiting to two large trials:
- AZTEC TRIAL
The AZithromycin ThErapy for Chronic Lung Disease of Prematurity (AZTEC) study is a national clinical trial investigating if the antibiotic azithromycin can improve the lung outcomes of premature babies who are born at less than 30 weeks of gestational age.
- FEED-1 TRIAL
A trial to determine the best way to feed babies born between 30 and 33 weeks, comparing two different methods: gradual milk feeds and full milk feeds.
If your baby is eligible for a study, you may be approached by a member of our team to discuss possible participation in a trial. Please note that this is completely optional, and there is no obligation to participate. If you do choose to participate, you will be helping hugely, and play a very important role in helping to advance neonatal care.